Occult brain metastasis is identified in about 4 percent of patients with metastatic renal cell carcinoma (mRCC).
Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.
Study researchers evaluated the incidence and risk factors for seizure development among patients with brain metastases.
The incidence of venous thromboembolism and major bleeding is high among patients with primary central nervous system lymphoma.
Findings from the study showed 44% of patients treated with berubicin experienced a statistically significant improvement in progression free survival.
Treatment disparities may explain worse outcomes for pediatric black and Hispanic brain cancer patients.
In the era of increasing survival of cancer patients, there are also changes in the presentation and outcomes of patients with pituitary metastasis.
The application is supported by data from 2 pivotal open-label, randomized phase 3 trials (SIOPEL 6 and ACCL0431), which compared the efficacy of sodium thiosulfate plus cisplatin to cisplatin alone for the prevention of cisplatin-induced hearing loss.
Death anxiety is common in patients with metastatic cancer, including those with metastatic non-small cell lung carcinoma.
An open-source smartphone and web application has been developed to help predict clinical malignancy and survival outcomes for meningioma.